Moreover, the percentage of FITC-TRPV2 in A549 was 99.76 ± 0.23%, 99.9 ± 0.03% in NCI-H2228, and 91.95 ± 0.55% in HCC-827 (Supplementary Figure S2B). The gene discussed is TRPV2; the disease is hepatocellular carcinoma.